Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study (Q44529174)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 July 2003
edit
Language Label Description Also known as
English
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study
scientific article published on 28 July 2003

    Statements

    Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study (English)
    Peter M Okin
    Sverker Jern
    Stevo Julius
    Markku S Nieminen
    Steven Snapinn
    Katherine E Harris
    Peter Aurup
    Jonathan M Edelman
    Bjorn Dahlof
    Losartan Intervention for Endpoint reduction in hypertension Study Investigations
    28 July 2003
    684-690

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit